WBG-14424-24965
2 vaccinations
2 coded responses
26 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 600 / IL
- Registered
- 2021-04-12
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-12
Registered in v-safe
-
2021-04-12
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-12
Health check-in — day 0, dose 1Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-04-13
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-14
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fever · HeadacheAdult check-in
-
2021-04-15
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain · Fatigue or tiredness, DiarrheaAdult check-in
- 2021-04-16
- 2021-04-17
- 2021-04-19
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-19
- 2021-05-24
- 2021-07-12
- 2021-10-13
-
2022-01-21
Dose 2 — Moderna
- 2022-01-21
-
2022-01-22
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Fever · Headache · Be unable to work or attend school, Be unable to do your normal daily activitiesAdult check-in
- 2022-01-23
- 2022-01-24
- 2022-01-25
- 2022-01-27
- 2022-02-04
- 2022-02-13
-
2022-02-18
Survey response — day 28, dose 2MedDRA: Headache — Feeling: GoodFree text: Frequent headachesMedDRA releases: 2024-11 · check-in free text available
- 2022-04-22
- 2022-07-23
-
2023-01-21
Survey response — 12 months, dose 2MedDRA: Chills, Cough, Pyrexia, Respiratory tract congestion — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationMedDRA releases: 2024-11
-
2023-01-21
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2023-01-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-12 | Janssen/Johnson & Johnson | |
| 2 | 2022-01-21 | Moderna | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2023-01-21 | Unsuccessful |
Free text
Release 11 — day 28, dose 2
Symptoms: Frequent headaches
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chills | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release